New dressing aims to ease pain after HS surgery

NCT ID NCT07316192

Recruiting now Symptom relief Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compares a new wound dressing, Pelashield PainGuard, to the standard Restrata dressing for people with severe hidradenitis suppurativa (HS) who need surgery. The new dressing contains silver to fight bacteria and lidocaine to numb pain. Researchers will track healing time, infections, and painkiller use in 10 patients, comparing them to past cases. The goal is to see if the new dressing improves recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pelashield PainGuard wound dressing (contains silver and lidocaine)
What this could lead to: If it works, this could offer a better healing experience for HS patients after surgery, with less pain and fewer infections.
What could go wrong: This is a very small study (10 people) and not randomized, so results may not apply to everyone. The new dressing might not outperform the current standard.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hidradenitis suppurativa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIDRADENITIS SUPPURATIVA (HS)

Contacts and locations

Locations

University Hospital
RECRUITING

Newark, New Jersey, 07103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.